AIO vs HTBK
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The Advanced Deterministic Scorecard reveals a critically weak financial health with a Piotroski F-Score of just 1/9, indicating severe operational and accounting deficiencies. Despite a low P/E ratio of 5.36 and a dividend yield of 7.96%, profitability metrics are entirely flat at 0.00%, and most financial data is unavailable or non-disclosed, raising transparency concerns. The technical trend score of 0/100 signals strong bearish momentum, and the lack of analyst coverage further limits confidence in forward visibility. While the dividend appears sustainable with a 42.65% payout ratio, the absence of earnings, ROE, ROA, and debt metrics creates substantial risk for long-term value preservation.
HTBK presents a stable financial profile with a Piotroski F-Score of 4/9 and is currently undervalued relative to its Graham Number ($14.23) and Intrinsic Value ($23.01). The company exhibits exceptional earnings growth (45.2% YoY) and a consistent track record of beating quarterly estimates over the last 25 quarters. However, a severely bearish technical trend (10/100) and modest ROE (6.84%) suggest caution regarding short-term timing. Overall, the strong fundamental growth and valuation discount outweigh the current technical weakness.
Compare Another Pair
Related Comparisons
AIO vs HTBK: Head-to-Head Comparison
This page compares Virtus Artificial Intelligence & Technology Opportunities Fund (AIO) and Heritage Commerce Corp (HTBK) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.